Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225803 · ClinicalTrials.gov registry record · NA
Management of Dyssynergic Defecation
A NA study of Constipation and Dyssynergic Defecation, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07225803: Recruiting NA study of Constipation and Dyssynergic Defecation, sponsored by Mayo Clinic.
NCT07225803 is a NA study of Constipation and Dyssynergic Defecation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants, roughly in line with the 202-participant average among 54 other Constipation trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225803, a NA study of Constipation and Dyssynergic Defecation, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to better understand constipation and improve biofeedback treatments.
Primary Outcome
Rectoanal gradient during evacuation is the pressure difference between the rectum and the anal canal during simulated evacuation, measured in millimeters of mercury (mmHg).
Conditions Studied
Interventions
- BEHAVIORAL Biofeedback
- BEHAVIORAL Inspiratory muscle training (IMT)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2029-07 |
| Phase | NA |
What NCT07225803 shows while recruiting
NCT07225803 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 202-participant average among 54 other Constipation trials with a reported enrollment target.
The record links to 2 conditions, with Constipation appearing as the primary indexed condition, and to 2 interventions - of which Biofeedback is the first listed.
NCT07225803 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07225803 about?
NCT07225803 is a clinical study titled "Management of Dyssynergic Defecation". The purpose of this research is to better understand constipation and improve biofeedback treatments.
What is the current status of trial NCT07225803?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-07-18. Estimated completion is 2029-07.
What conditions does trial NCT07225803 study?
This clinical trial studies the following conditions: Constipation, Dyssynergic Defecation.
What interventions are being tested in trial NCT07225803?
The interventions under investigation include: Biofeedback (BEHAVIORAL), Inspiratory muscle training (IMT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07225803?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225803 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07225803's enrollment target sits among peer trials
200 10th of 54 higher than 45 of 54 other Constipation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimization of Postoperative Bowel Habits
RECRUITING · NA
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
Fecobionics in Biofeedback Therapy in Dyssynergia Patients
RECRUITING · NA
-
Understanding Mechanisms of Normal and Disordered Defecation
RECRUITING · NA
-
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes
RECRUITING · NA
-
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI